Pre-existing immunity modulates responses to mRNA boosters

Mostrar otras versiones (1)

mRNA vaccines have shown high efficacy in preventing severe COVID-19, but breakthrough infections, emerging variants and waning antibody levels have warranted the use of boosters. Although mRNA boosters have been widely implemented, the extent to which pre-existing immunity influences the efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dangi, Tanushree, Sanchez, Sarah, Lew, Min Han, Visvabharathy, Lavanya, Richner, Justin, Koralnik, Igor J., Penaloza-MacMaster, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258286/
https://www.ncbi.nlm.nih.gov/pubmed/35794898
http://dx.doi.org/10.1101/2022.06.27.497248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258286/
https://www.ncbi.nlm.nih.gov/pubmed/35794898
http://dx.doi.org/10.1101/2022.06.27.497248

Ejemplares similares